| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/01/2010 | WO2010071934A1 Modulation of platelet activation |
| 07/01/2010 | WO2010071924A1 Osteoarthritis treatment |
| 07/01/2010 | WO2010071923A1 Pain treatment |
| 07/01/2010 | WO2010056709A3 Eimeria vaccine for turkeys |
| 07/01/2010 | WO2010047928A3 Methods and compositions for treatment of fibrosis |
| 07/01/2010 | WO2010042876A9 Targeting of antigen presenting cells with immunonanotherapeutics |
| 07/01/2010 | WO2010040033A3 Methods and compositions for modulating an immune response with immunogenic oligonucleotides |
| 07/01/2010 | WO2010039563A3 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens |
| 07/01/2010 | WO2010037864A3 Inhibition of plgf to treat philadelphia chromosome positive leukemia |
| 07/01/2010 | WO2010036970A3 Influenza vaccines, antigens, compositions, and methods |
| 07/01/2010 | WO2010035292A8 The use of a human monoclonal anti-hcv antibody as a medicament for the therapeutic treatment and prevention of hcv infections |
| 07/01/2010 | WO2010030653A3 Nurr1 interacting protein (nuip) |
| 07/01/2010 | WO2010028306A3 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions |
| 07/01/2010 | WO2010027818A3 Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use |
| 07/01/2010 | WO2010027473A3 Immunogenic escherichia coli heat stable enterotoxin |
| 07/01/2010 | WO2010008862A3 Live attenuated catfish vaccine and method of making |
| 07/01/2010 | WO2009059325A8 Multitype hpv peptide compositions and methods for treatment or prevention of human papillomavirus infection |
| 07/01/2010 | US20100169992 Fgfr4 antibodies |
| 07/01/2010 | US20100169989 Use of Follistatin-Like Related Gene (FLRG) to Increase Muscle Mass |
| 07/01/2010 | US20100168720 System for providing fluid flow to nerve tissues |
| 07/01/2010 | US20100168401 Method, composition and kit for detecting phosphatidylserine (PS) on cell membranes |
| 07/01/2010 | US20100168397 Therapeutic use of anti-cs1 antibodies |
| 07/01/2010 | US20100168214 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 07/01/2010 | US20100168187 Therapeutic combination |
| 07/01/2010 | US20100168027 Bpc-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 07/01/2010 | US20100168021 Urocortin proteins and uses thereof |
| 07/01/2010 | US20100168002 Therapeutic peptides |
| 07/01/2010 | US20100167352 Infectious clones |
| 07/01/2010 | US20100167321 Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same |
| 07/01/2010 | US20100167265 Vaccine against infectious agents having an intracellular phase, composition for the treatment and prevention of hiv infections, antibodies and method of diagnosis |
| 07/01/2010 | US20100166874 Technology for Preparation of Macromolecular Microspheres |
| 07/01/2010 | US20100166872 Novel improved compositions for cancer therapy |
| 07/01/2010 | US20100166862 Local Complement Inhibition for Treatment of Complement-Mediated Disorders |
| 07/01/2010 | US20100166843 Pharmaceutical composition comprising a campothecin derivative |
| 07/01/2010 | US20100166840 Liposome having lipid membrane containing bacterial cell component |
| 07/01/2010 | US20100166829 Active agent eluting matrices with particulates |
| 07/01/2010 | US20100166808 Method of Facilitating Intracellular Uptake or Transcellular Transport of Cargo Using Nanocarriers Containing Optimal Surface Densities of Integrin-Specific Ligands |
| 07/01/2010 | US20100166805 Modulation of immunostimulatory properties by small oligonucleotide-based compounds |
| 07/01/2010 | US20100166804 Methods |
| 07/01/2010 | US20100166803 Eimeria vaccine for turkeys |
| 07/01/2010 | US20100166802 Methods and reagents for decreasing clinical reaction to allergy |
| 07/01/2010 | US20100166801 Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis |
| 07/01/2010 | US20100166800 Recombinant attenuated clostridium organisms and vaccine |
| 07/01/2010 | US20100166799 Adenoviral vectors and methods and uses related thereto |
| 07/01/2010 | US20100166798 Method and kit for treatment/prevention of hair loss |
| 07/01/2010 | US20100166797 Gammaretrovirus associated with cancer |
| 07/01/2010 | US20100166795 Novel Adjuvant Compounds |
| 07/01/2010 | US20100166794 Plasmodium liver stage antigens |
| 07/01/2010 | US20100166793 Protease-resistant modified seb and vaccine containing the same |
| 07/01/2010 | US20100166792 Antigenic Polypeptides |
| 07/01/2010 | US20100166791 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/01/2010 | US20100166790 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris) |
| 07/01/2010 | US20100166789 Proteins for use in diagnosing and treating infection and disease |
| 07/01/2010 | US20100166788 Immunogens from uropathogenic escherichia coli |
| 07/01/2010 | US20100166787 Vaccines and methods for using the same |
| 07/01/2010 | US20100166786 A mycobacterium tuberculosis fusion protein and uses thereof |
| 07/01/2010 | US20100166785 lipopeptide or lipoprotein that is not only highly immunogenic itself but also can enhance the immunogenicity of other antigens; vaccine |
| 07/01/2010 | US20100166784 Method and compositions for modulating th17 cell development |
| 07/01/2010 | US20100166783 Method |
| 07/01/2010 | US20100166782 Clip inhibitors and methods of modulating immune function |
| 07/01/2010 | US20100166781 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/01/2010 | US20100166780 CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity |
| 07/01/2010 | US20100166779 Monoclonal Antibodies Against Claudin-18 for Treatment of Cancer |
| 07/01/2010 | US20100166778 Toll-Like Receptor 3 Antagonists |
| 07/01/2010 | US20100166777 Hematopoietic cells that express mosc-1 |
| 07/01/2010 | US20100166776 Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors |
| 07/01/2010 | US20100166775 S100a9 interaction screening method |
| 07/01/2010 | US20100166774 Stable Protein Formulations |
| 07/01/2010 | US20100166773 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 07/01/2010 | US20100166772 ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n |
| 07/01/2010 | US20100166771 detecting NTHi bacteria in a biological sample using a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 599; vaccines and methods of treating and preventing NTHi related disorders such as NTHi infection of the middle ear and/or the nasopharynx |
| 07/01/2010 | US20100166770 Antagonists of bacterial sequences |
| 07/01/2010 | US20100166769 High-yield Transgenic Mammalian Expression System for Generating Virus-like Particles |
| 07/01/2010 | US20100166768 High Affinity Human Antibodies to PCSK9 |
| 07/01/2010 | US20100166767 Engineered anti-il-23r antibodies |
| 07/01/2010 | US20100166766 Engineered anti-tslp antibody |
| 07/01/2010 | US20100166765 Benzoquinazoline derivatives |
| 07/01/2010 | US20100166764 Anti-myostatin antibodies |
| 07/01/2010 | US20100166763 Method for determining the immunogenicity of an antigen |
| 07/01/2010 | US20100166762 Method of treating a pathological syndrome |
| 07/01/2010 | US20100166761 Compositions and methods for the treatment of immune related diseases |
| 07/01/2010 | US20100166760 Methods of reducing phosphate absorption |
| 07/01/2010 | US20100166759 Metallothionein-Derived Peptide Fragments |
| 07/01/2010 | US20100166758 Novel antibody molecules and nucleic acids |
| 07/01/2010 | US20100166757 Antibodies against monocyte chemotactic proteins |
| 07/01/2010 | US20100166756 Method for treating an autoimmune disease using a soluble ctla4 molecule and a dmard or nsaid |
| 07/01/2010 | US20100166755 Anti-egfr antibodies |
| 07/01/2010 | US20100166754 Methods and Compositions For Treating Autoimmune Diseases or Conditions |
| 07/01/2010 | US20100166753 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/01/2010 | US20100166752 Anti A Beta Antibody Formulation |
| 07/01/2010 | US20100166751 Cancer therapy using whole glucan particles and antibodies |
| 07/01/2010 | US20100166750 Indications for Anti-IL-1 Beta Therapy |
| 07/01/2010 | US20100166749 Polypeptide variants with altered effector function |
| 07/01/2010 | US20100166748 C5 Antigens and Uses Thereof |
| 07/01/2010 | US20100166747 Methods and compositions for treating tumor diseases |
| 07/01/2010 | US20100166746 High potency recombinant antibodies, methods for producing them and use in cancer therapy |
| 07/01/2010 | US20100166745 Transferrin receptor antibodies |
| 07/01/2010 | US20100166744 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease |
| 07/01/2010 | US20100166743 Method of detecting ocular diseases and pathologic conditions and treatment of same |
| 07/01/2010 | US20100166742 Method for promoting immunotherapies |